FENC

Fennec Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 6/10
  • Value↓ 1/10
Fennec Pharmaceuticals sales and earnings growth
FENC Growth
Good
  • Revenue Y/Y↓ -6.09%
  • EPS Y/Y↓ -1600.00%
  • FCF Y/Y↓ -146.23%
Fennec Pharmaceuticals gross and profit margin trends
FENC Profitability
Neutral
  • Gross margin ↑ 91.60%
  • EPS margin↓ -21.80%
  • ROIC 5Y↓ -27.39%
Fennec Pharmaceuticals net debt vs free cash flow
FENC Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -3.6

Fennec Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks